The Department of Veterans Affairs is seeking sources capable of providing Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing for patient specimens at the Richard L. Roudebush VAMC. The required testing must analyze at least 600 targeted genes and produce detailed treatment plans for patients with changes in their diagnosis. This is a one-year, firm fixed price contract, though no specific budget amount is mentioned. Responses to this sources sought notice are due by Tuesday, July 14, 2026, at 12pm EST. Performance of services will be at the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana.